Skip to main content

Table 1 Bladder cancer patients

From: Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

 

Patient number N (%)

 

Total

qPCR analysis

ELISA analysis

Chemotaxis

Patients

23(100)

20(100)

11(100)

3(100)

Male

15(65)

14(70)

6(55)

1(33)

Female

8(35)

6(30)

5(45)

2(67)

Tumor stage:

    

Stage 0

4(17)

4(20)

2(18)

 

Stage 0is

1(4)

1(5)

  

Stage 1

6(26)

5(25)

3(27)

1(33)

Stage 2

2(9)

2(10)

1(9)

 

Stage 3

8(35)

6(30)

4(36)

2(67)

Stage 4

2(9)

2(10)

1(9)

 

Prior treatment:

    

None

15(65)

13(65)

7(64)

2(67)

BCG

5(22)

5(25)

2(18)

 

Other treatment

3(13)

2(10)

2(18)

1(33)